Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
26.33B | 21.36B | 13.72B | 8.42B | 5.40B | 4.38B | Gross Profit |
6.38B | 6.42B | 3.75B | 2.11B | 1.38B | 1.23B | EBIT |
2.82B | 3.49B | 1.43B | 490.43M | 322.31M | 263.00M | EBITDA |
2.37B | 4.35B | 1.93B | 819.00M | 562.83M | 405.01M | Net Income Common Stockholders |
454.00M | 2.03B | 784.00M | 255.71M | 241.42M | 148.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.59B | 3.31B | 2.61B | 814.76M | 496.36M | 1.35B | Total Assets |
40.45B | 31.52B | 19.21B | 9.02B | 4.79B | 3.47B | Total Debt |
22.82B | 20.11B | 11.20B | 6.60B | 3.03B | 2.04B | Net Debt |
16.23B | 16.80B | 8.59B | 5.78B | 2.53B | 685.19M | Total Liabilities |
31.03B | 24.38B | 13.84B | 8.15B | 4.09B | 2.98B | Stockholders Equity |
9.42B | 7.14B | 5.37B | 864.74M | 693.47M | 487.00M |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.94B | -741.00M | -78.18M | -392.99M | -209.21M | Operating Cash Flow |
0.00 | 2.56B | 1.14B | 378.19M | 201.03M | 313.13M | Investing Cash Flow |
0.00 | -5.66B | -2.04B | -633.05M | -648.06M | -551.00M | Financing Cash Flow |
0.00 | 3.80B | 2.70B | 573.26M | 489.42M | -818.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥394.99B | 23.38 | 1.51% | 0.36% | -3.73% | ||
70 Outperform | €1.31T | 34.43 | 17.11% | 0.86% | 21.84% | 85.45% | |
70 Outperform | ¥71.97B | 14.03 | 6.80% | 0.60% | -1.23% | ||
52 Neutral | $5.15B | 3.02 | -44.64% | 2.83% | 16.44% | -0.47% | |
52 Neutral | ¥20.08B | 159.73 | 1.40% | 39.10% | -90.57% |